Clinical Chemistry Analyzers Market
According to Intent Market Research, the Clinical Chemistry Analyzers Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 4.4% to touch USD 16.7 billion by 2030. The clinical chemistry analyzers market is dominated by key players such as Roche Diagnostics, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, and Sysmex Corporation.